DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Prism Medico & Pharmacy Ltd (PRISMMEDI) share price today?

Prism Medico & Pharmacy Ltd (PRISMMEDI) is trading at ₹29.23 on the BSE, up 5.52% on the day. Source: DocStoX.

What is the PE ratio of Prism Medico & Pharmacy Ltd?

Prism Medico & Pharmacy Ltd has a price-to-earnings (PE) ratio of 120.4 in the Financial Services sector.

What is the market capitalisation of Prism Medico & Pharmacy Ltd?

Prism Medico & Pharmacy Ltd has a market capitalisation of approximately ₹41 crore.

Prism Medico & Pharmacy Ltd

PRISMMEDI·BSE·Financial Services

₹29.23▲ +1.53 (+5.52%)

Financial Services · Finance

A steady, established business

Day₹27.05

₹30.40

52W₹12

₹3476%

Open

₹30.40

High

₹30.40

Low

₹27.05

Prev Close

₹27.70

Volume

805

VWAP

₹29.19

Snapshot

Key fundamentals

Market Cap

₹41 Cr

P/E Ratio

120.40Expensive

P/B Ratio

1.64

EPS

₹0.24

Book Value

₹16.89

ROE

0.31%Weak

ROCE

0.08%Weak

Dividend Yield

0.00%

Debt / Equity

0.17Low

Face Value

₹10.00

52W High

₹34.49

52W Low

₹12.49

Sector

Financial Services

Industry

Finance

Avoid

None moatVery High uncertainty

Fair value estimate

₹14

▼ 52.1%downside

Trading at ₹29 — 52% above our estimate

BearFair valueBull

₹12₹14₹16

/100

Business quality — Watch the fundamentals

Growth 50Profitability 0Efficiency 0Valuation 46

Plain English

Our view

A steady, established business
Low debt relative to equity
Weak returns on equity (0%)

Strengths

Low debt relative to equity

Risks

Weak returns on equity (0%)
Expensive — trades at 120× earnings

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

120.4Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

0.3%Weak

Above 15% is considered healthy for Indian equities

ROCE

0.1%Weak

Above 18% means capital is working hard

Debt/Eq

0.17Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹41 Cr

P/B

1.64

EPS

₹0.24

Div Yield

—

What changed

Recent changes

Promoters+4.71% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 120.4×

Growth

N/A

No history

Profitability

Modest

0.3% ROE

Financial health

Rock solid

D/E 0.17

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹23,498 Cr

Trades24

VWAP₹29.19

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

No growth history

Not enough annual history to compute CAGR.

Profile

Pros

Company is almost debt free.
Stock is trading at 1.09 times its book value

Watch-outs

Cons

Promoter holding is low: 30.2%
Company has a low return on equity of 0.55% over last 3 years.
Company has high debtors of 588 days.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 May 2026

Promoters raised their stake by 4.71 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

30%

Promoter

Promoters

30.2%+4.71

Public

66.0%0.00

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

3.8%

Total shareholders

4,300+5 QoQ

Quarterly trend

Ownership over time

Q1 FY27

Promoter30.20%

Public66.00%

Others3.80%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1985, Prism Medico & Pharmacy Ltd manufactures, trades, and distributes chemicals, medicines, pharmaceuticals, cosmetics, and related products[1]